HHH

THE HYDRATION PHARMACEUTICALS COMPANY LIMITED

No trades
See on Supercharts
Market capitalization
‪3.45 M‬AUD
−0.062AUD
‪−12.21 M‬AUD
‪15.13 M‬AUD
‪227.80 M‬
Beta (1Y)
−0.61

About THE HYDRATION PHARMACEUTICALS COMPANY LIMITED

CEO
Oliver Baker
Headquarters
Melbourne
Founded
2017
ISIN
AU0000187957
FIGI
BBG013HLW074
The Hydration Pharmaceuticals Co. Ltd. markets and sells a range of liquid, tablet and powder healthy hydration solutions products. The company was founded on July 24, 2017 and is headquartered in Melbourne, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HPC is 0.013 AUD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange THE HYDRATION PHARMACEUTICALS COMPANY LIMITED stocks are traded under the ticker HPC.
HPC stock is 7.69% volatile and has beta coefficient of −0.61. Check out the list of the most volatile stocks — is THE HYDRATION PHARMACEUTICALS COMPANY LIMITED there?
Yes, you can track THE HYDRATION PHARMACEUTICALS COMPANY LIMITED financials in yearly and quarterly reports right on TradingView.
HPC stock hasn't changed in a week, the month change is a 18.75% fall, over the last year THE HYDRATION PHARMACEUTICALS COMPANY LIMITED has showed a 83.03% decrease.
HPC net income for the last quarter is ‪−7.01 M‬ AUD, while the quarter before that showed ‪−5.23 M‬ AUD of net income which accounts for −34.04% change. Track more THE HYDRATION PHARMACEUTICALS COMPANY LIMITED financial stats to get the full picture.
No, HPC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HPC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THE HYDRATION PHARMACEUTICALS COMPANY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
HPC reached its all-time high on Dec 15, 2021 with the price of 0.385 AUD, and its all-time low was 0.013 AUD and was reached on Mar 20, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THE HYDRATION PHARMACEUTICALS COMPANY LIMITED technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THE HYDRATION PHARMACEUTICALS COMPANY LIMITED stock shows the sell signal. See more of THE HYDRATION PHARMACEUTICALS COMPANY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THE HYDRATION PHARMACEUTICALS COMPANY LIMITED EBITDA is ‪−11.66 M‬ AUD, and current EBITDA margin is −77.10%. See more stats in THE HYDRATION PHARMACEUTICALS COMPANY LIMITED financial statements.